1189671-48-4
1189671-48-4
Chemical Structure
Etravirine-13C3
Synonym(s): R165335-13C3; TMC125-13C3
- CAS No.: 1189671-48-4
- Formula:C1713C3H15BrN6O
- Molecular Weight:438.25
InChIKey: PYGWGZALEOIKDF-WTZVUXPESA-N
SMILES: Br[13C]1=[13C](N=C(N=[13C]1N)NC2=CC=C(C=C2)C#N)OC3=C(C=C(C=C3C)C#N)C
Biological Activity: Etravirine-13C3 (R165335-13C3) is the 13C-labeled Etravirine (HY-90005). Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Etravirine-13C3 | Etravirine-13C3 (R165335-13C3) is the 13C-labeled Etravirine (HY-90005). Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine (Standard) | ≥98% | Etravirine (Standard) is the analytical standard of Etravirine. This product is intended for research and analytical applications. Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine-d4 | 98.31% | Etravirine-d4 is the deuterium labeled Etravirine. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine-d8 | Etravirine-d8 is the deuterium labeled Etravirine. Etravirine (R165335) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etravirine | 99.07% | Etravirine (R165335; TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
